Published in
Wiley Open Access, United European Gastroenterology Journal, 2024
DOI: 10.1002/ueg2.12558
Links
Tools
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well
This paper is made freely available by the publisher.
Full text: Download
Data provided by 